Sagimet Biosciences Statistics

Total Valuation

SGMT has a market cap or net worth of $89.02 million. The enterprise value is -$69.24 million.

Market Cap	89.02M
Enterprise Value	-69.24M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

SGMT has 32.20 million shares outstanding. The number of shares has increased by 199.71% in one year.

Current Share Class	30.67M
Shares Outstanding	32.20M
Shares Change (YoY)	+199.71%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	7.18%
Owned by Institutions (%)	41.74%
Float	20.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.57
P/TBV Ratio	0.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 34.30, with a Debt / Equity ratio of 0.00.

Current Ratio	34.30
Quick Ratio	33.96
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -36.92% and return on invested capital (ROIC) is -27.56%.

Return on Equity (ROE)	-36.92%
Return on Assets (ROA)	-26.49%
Return on Invested Capital (ROIC)	-27.56%
Return on Capital Employed (ROCE)	-34.95%
Revenue Per Employee	n/a
Profits Per Employee	-$3.25M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.39% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.39%
50-Day Moving Average	3.35
200-Day Moving Average	3.99
Relative Strength Index (RSI)	49.81
Average Volume (20 Days)	679,193

Short Selling Information

The latest short interest is 3.96 million, so 12.28% of the outstanding shares have been sold short.

Short Interest	3.96M
Short Previous Month	4.19M
Short % of Shares Out	12.28%
Short % of Float	19.30%
Short Ratio (days to cover)	12.01

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-54.45M
Pretax Income	-27.92M
Net Income	-45.57M
EBITDA	n/a
EBIT	-54.45M
Earnings Per Share (EPS)	-$1.45

Full Income Statement

Balance Sheet

The company has $151.25 million in cash and $78,000 in debt, giving a net cash position of $158.58 million or $4.93 per share.

Cash & Cash Equivalents	151.25M
Total Debt	78,000
Net Cash	158.58M
Net Cash Per Share	$4.93
Equity (Book Value)	155.81M
Book Value Per Share	4.84
Working Capital	148.32M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-42.44M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SGMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-199.71%
Shareholder Yield	-199.71%
Earnings Yield	-51.00%
FCF Yield	n/a

Analyst Forecast

The average price target for SGMT is $25.67, which is 828.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.67
Price Target Difference	828.39%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-0.89%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2